. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease. Alzheimers Res Ther. 2018 Feb 26;10(1):25. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
MCP-1
(CSF)
AD
(116)
342 ± 96
pg/mL
Electrochemiluminescence;
V-PLEX Human Biomarker 40-Plex Kit;
Meso Scale Discovery
McKhann et al., 2011
MCP-1
(CSF)
CTRL-
Other Controls
(85)
323 ± 112
pg/mL
Electrochemiluminescence;
V-PLEX Human Biomarker 40-Plex Kit;
Meso Scale Discovery
MCP-1
(CSF)
FTD
(20)
336 ± 112
pg/mL
Electrochemiluminescence;
V-PLEX Human Biomarker 40-Plex Kit;
Meso Scale Discovery
Gorno-Tempini et al., 2011
MCP-1
(CSF)
PD
(16)
335 ± 73
pg/mL
Electrochemiluminescence;
V-PLEX Human Biomarker 40-Plex Kit;
Meso Scale Discovery
Hughes et al., 1992
sTREM2
(CSF)
AD
(116)
4315 ± 2235
pg/mL
Electrochemiluminescence;
Other/Not Specified;
In-house
McKhann et al., 2011
sTREM2
(CSF)
CTRL-
Other Controls
(85)
2994 ± 2269
pg/mL
Electrochemiluminescence;
Other/Not Specified;
In-house
sTREM2
(CSF)
DLB
(11)
4222 ± 1675
pg/mL
Electrochemiluminescence;
Other/Not Specified;
In-house
sTREM2
(CSF)
FTD
(20)
3343 ± 2031
pg/mL
Electrochemiluminescence;
Other/Not Specified;
In-house
Gorno-Tempini et al., 2011
sTREM2
(CSF)
PD
(16)
4186 ± 2243
pg/mL
Electrochemiluminescence;
Other/Not Specified;
In-house
Hughes et al., 1992

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.